Vivos RDGL
OTC RDGL
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vivos (RDGL) Revenue (2010 - 2025)

Vivos' (RDGL) quarterly Revenue came in at $24752.0 in Q4 2025, up 395.54% year-over-year from $4995.0 in Q4 2024, and up 1217.3% quarter-over-quarter from $1879.0 in Q3 2025.

Analysis

Vivos (RDGL) Revenue (2010 - 2025) Analysis & Trends

Vivos has disclosed Revenue across 16 years of filings, most recently posting $24752.0 for Q4 2025.

  • In Q4 2025, Revenue rose 395.54% year-over-year to $24752.0; the TTM figure through Dec 2025 stood at $68379.0 (up 144.25% YoY), while the FY2025 annual figure was $68379.0, up 144.25% from the prior year.
  • Revenue came in at $24752.0 for Q4 2025 at Vivos, up from $1879.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $26748.0 in Q1 2025 to a low of $1879.0 in Q3 2025.
  • Average Revenue over 5 years is $10453.8, with a median of $6750.0 recorded in 2022.
  • The largest YoY upside for Revenue was 494.4% in 2025 against a maximum downside of 62.42% in 2025.
  • Over 5 years, Revenue stood at $14887.0 in 2021, then plunged by 56.34% to $6499.0 in 2022, then rose by 7.71% to $7000.0 in 2023, then declined by 28.64% to $4995.0 in 2024, then surged by 395.54% to $24752.0 in 2025.
  • Per Business Quant data, the three most recent Revenue figures were $24752.0 in Q4 2025, $1879.0 in Q3 2025, and $15000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 12.59 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 2.89 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 9.76 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 6.59 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 5.44 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 1.74 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 2.78 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 1.31 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 1.49 Bn
10 Vivos 23.21 Mn 23.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 24,752.00
Sep 30, 2025 1,879.00
Jun 30, 2025 15,000.00
Mar 31, 2025 26,748.00
Dec 31, 2024 4,995.00
Sep 30, 2024 5,000.00
Jun 30, 2024 13,500.00
Mar 31, 2024 4,500.00
Sep 30, 2023 7,000.00
Jun 30, 2023 6,500.00
Mar 31, 2023 6,000.00
Dec 31, 2022 6,499.00
Sep 30, 2022 6,500.00
Jun 30, 2022 10,500.00
Mar 31, 2022 13,000.00
Sep 30, 2021 14,887.00
Sep 30, 2020 7,000.00
Dec 31, 2019 1,500.00
Sep 30, 2019 8,000.00
Mar 31, 2018 17,583.00